GWM
VCSH icon

Geneos Wealth Management’s Vanguard Short-Term Corporate Bond ETF VCSH Stock Holding History

Geneos Wealth Management’s Portfolio VCSH Stock Details VCSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
13,281
+498
+4% +$39.7K 0.02% 499
2025
Q4 		$1.02M Sell
12,783
-381
-3% -$30.4K 0.02% 499
2025
Q3 		$1.05M Buy
13,164
+109
+0.8% +$8.67K 0.03% 475
2025
Q2 		$1.04M Sell
13,055
-15,762
-55% -$1.24M 0.03% 523
2025
Q1 		$2.27M Buy
28,817
+16,934
+143% +$1.33M 0.03% 457
2024
Q4 		$927K Buy
11,883
+361
+3% +$28.3K 0.03% 438
2024
Q3 		$915K Buy
11,522
+1,201
+12% +$94.3K 0.03% 427
2024
Q2 		$798K Sell
10,321
-1,249
-11% -$96.1K 0.04% 397
2024
Q1 		$894K Sell
11,570
-473
-4% -$36.5K 0.04% 367
2023
Q4 		$932K Buy
12,043
+1,761
+17% +$133K 0.05% 337
2023
Q3 		$773K Sell
10,282
-2,093
-17% -$158K 0.04% 364
2023
Q2 		$936K Sell
12,375
-246
-2% -$18.7K 0.05% 325
2023
Q1 		$962K Sell
12,621
-1,403
-10% -$106K 0.06% 296
2022
Q4 		$1.05M Sell
14,024
-2,130
-13% -$159K 0.06% 265
2022
Q3 		$1.2M Sell
16,154
-1,033
-6% -$78.7K 0.08% 224
2022
Q2 		$1.31M Sell
17,187
-1,575
-8% -$121K 0.07% 266
2022
Q1 		$1.47M Sell
18,762
-2,418
-11% -$192K 0.06% 269
2021
Q4 		$1.72M Sell
21,180
-1,079
-5% -$88.2K 0.07% 276
2021
Q3 		$1.83M Buy
22,259
+1,981
+10% +$164K 0.07% 261
2021
Q2 		$1.68M Sell
20,278
-178,421
-90% -$14.8M 0.07% 264
2021
Q1 		$16.4M Sell
198,699
-9,700
-5% -$804K 0.46% 47
2020
Q4 		$1.74M Buy
208,399
+183,748
+745% +$15.2M 0.07% 254
2020
Q3 		$2.04M Buy
24,651
+130
+0.5% +$10.8K 0.11% 194
2020
Q2 		$2.02M Sell
24,521
-70
-0.3% -$5.69K 0.11% 189
2020
Q1 		$1.93M Sell
24,591
-10,283
-29% -$827K 0.13% 169
2019
Q4 		$2.82M Buy
34,874
+13,641
+64% +$1.11M 0.15% 165
2019
Q3 		$1.72M Buy
21,233
+13,980
+193% +$1.13M 0.1% 199
2019
Q2 		$585K Buy
7,253
+282
+4% +$22.5K 0.04% 374
2019
Q1 		$556K Buy
6,971
+200
+3% +$15.8K 0.04% 370
2018
Q4 		$527K Sell
6,771
-21
-0.3% -$1.63K 0.04% 358
2018
Q3 		$530K Sell
6,792
-123
-2% -$9.61K 0.04% 372
2018
Q2 		$540K Sell
6,915
-319
-4% -$24.9K 0.04% 317
2018
Q1 		$567K Sell
7,234
-21,828
-75% -$1.72M 0.05% 283
2017
Q4 		$2.3M Buy
29,062
+22,040
+314% +$1.76M 0.21% 123
2017
Q3 		$562K Buy
7,022
+1,311
+23% +$105K 0.06% 284
2017
Q2 		$457K Sell
5,711
-561
-9% -$44.8K 0.05% 312
2017
Q1 		$500K Sell
6,272
-1,485
-19% -$118K 0.05% 274
2016
Q4 		$615K Sell
7,757
-1,010
-12% -$80.6K 0.08% 215
2016
Q3 		$706K Sell
8,767
-35,686
-80% -$2.88M 0.1% 205
2016
Q2 		$3.59M Sell
44,453
-2,379
-5% -$191K 0.52% 41
2016
Q1 		$3.72M Buy
+46,832
New +$3.71M 0.57% 37

Other funds holding VCSH

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Geneos Wealth Management's VCSH Position: Q1 2026 in Review

Geneos Wealth Management increased its Vanguard Short-Term Corporate Bond ETF (VCSH) stake by 3.9% in Q1 2026, buying an estimated $39.7K and bringing the position to 13,281 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #499.

Geneos Wealth Management first reported a position in VCSH in Q1 2016 and has held it in 41 quarters since. The position peaked at $16.4M in Q1 2021. 1,457 funds tracked by Wall St. Rank hold VCSH as of Q1 2026.

  • Geneos Wealth Management held 13,281 shares of Vanguard Short-Term Corporate Bond ETF worth $1.05M as of Q1 2026.
  • Geneos Wealth Management bought 498 Vanguard Short-Term Corporate Bond ETF shares in Q1 2026, an estimated $39.7K.
  • Vanguard Short-Term Corporate Bond ETF made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #499 holding.
  • Geneos Wealth Management first reported a position in Vanguard Short-Term Corporate Bond ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Vanguard Short-Term Corporate Bond ETF position peaked at $16.4M in Q1 2021.
  • 1,457 funds tracked by Wall St. Rank held Vanguard Short-Term Corporate Bond ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.